GlobeNewswire News Roomยท2025-08-25 14:23Core Viewpoint - Class action lawsuits have been filed against Hims & Hers Health, iRobot Corporation, and Centene Corporation, alleging that these companies made materially false and misleading statements regarding their business operations and prospects, which led to investor losses [2][3][4]. Group 1: Hims & Hers Health, Inc. (NYSE: HIMS) - The class period for Hims is from April 29, 2025, to June 22, 2025, with a lead plaintiff deadline of August 25, 2025 [2]. - Allegations include deceptive promotion of illegitimate versions of Wegovy, risking patient safety, and a substantial risk of termination of collaboration with Novo Nordisk [2]. - Defendants' positive statements about the company's business were materially misleading and lacked a reasonable basis [2]. Group 2: iRobot Corporation (NASDAQ: IRBT) - The class period for iRobot is from January 29, 2024, to March 11, 2025, with a lead plaintiff deadline of September 5, 2025 [3]. - Allegations state that iRobot overstated the effectiveness of its Restructuring Plan post-Amazon Acquisition termination, raising doubts about its ability to operate profitably as a standalone company [3]. - Defendants' positive statements regarding the company's prospects were materially misleading and lacked a reasonable basis [3]. Group 3: Centene Corporation (NYSE: CNC) - The class period for Centene is from December 12, 2024, to June 30, 2025, with a lead plaintiff deadline of September 8, 2025 [4]. - Allegations include failure to disclose lower-than-anticipated enrollment and increased market morbidity based on preliminary analysis of over two-thirds of Centene's marketplace share [4]. - Defendants' positive statements about the company's business operations were materially misleading and lacked a reasonable basis [4].